During the New Years 2019 event of the Radboudumc, Mihai Netea, theme Infectious diseases and global health, was honored by Cees Buren, of our executive board, with the Radboudumc Medal.The Radboudumc Medal is the highest honor awarded annually to a person who has contributed significantly to the objective of the Radboudumc as top knowledge center for academic medicine and health.
Mihai received this highest honor of our Radboudumc for his excellent scientific research and he is one of the most successful medical specialists at the Radboudumc.
Related news items
A personal touch of Jaap ten Oever20 June 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Jaap ten Oever.read more
Radboudumc Master Prize for Mark van Goor18 June 2019
Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.read more
Pathogenic fungus can make artificial leather waterproof18 June 2019
Paul Verweij and Sybren de Hoog, theme Infectious diseases and global health, won the Bio Art & Design Award to further develop the development of waterproof synthetic leather.read more
A warm welcome for Hypatia fellow Daniele Tauriello18 June 2019
It is our pleasure to welcome a new research group leader and Hypatia fellow at RIMLS: Daniele Tauriello (dept Cell Biology).read more
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provide a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more